Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects Under Fed Conditions
Status:
NOT_YET_RECRUITING
Trial end date:
2025-09-30
Target enrollment:
Participant gender:
Summary
This is a single center, Phase 1, randomized, open-label, single-dose, 2 treatment, 2-period,2-sequence, crossover study designed to compare the pharmacokinetics (PK) of sapropterin between the Test and Reference products in healthy Participants.